Mass. Biotech Co. Hit With Stock Drop Suit Over New Drug

By Katryna Perera · July 31, 2023, 9:02 PM EDT

Massachusetts-based biotechnology company Aldeyra Therapeutics Inc. was hit with a proposed class action Monday by investors who claim the company and its top executives made false and misleading statements about a...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Paice et al v. Aldeyra Therapeutics, Inc. et al

Case Number

1:23-cv-11737

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

July 31, 2023